Target engagement of the systemic Stat3 inhibitor in APP/PS1 mice

Slides:



Advertisements
Similar presentations
Expression of follicular cell‐derived VEGF‐A and endothelial VEGFR is altered by different circulating TSH level Expression of follicular cell‐derived.
Advertisements

Effects of inhibiting inflammatory cell recruitment on fracture healing Treatment with CCR2 antagonist, INCB3344, led to impaired fracture healing compared.
Loss of Hdac3 impairs Ar signaling in mouse prostate tissues and has no effect on apoptosis Loss of Hdac3 impairs Ar signaling in mouse prostate tissues.
Juxtavascular astrocytes are enriched in nuclear Aryl hydrocarbon receptor immunostaining at the stab wound injury site in WT mice Juxtavascular astrocytes.
Activation of EphB4 by ephrinB2‐Fc prevents aberrant angiogenesis
Reduced astrocyte proliferation results in increased immune cell infiltration into the injured GM Reduced astrocyte proliferation results in increased.
Amyloid‐associated gliosis in APPPS1‐21 transgenic mice.
Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice.
Fig. 2. Increased Aβ plaque load in 16-month-old APP/PS1;C3 KO mice.
PERK activator decreases pathological tau species in vivo
Cognitive deficits in APPPS1‐21 mice.
Neuro‐inflammatory cytokines, brain microglial activation, and working memory deficits are normalized using LV.IDS.ApoEII, but not LV.IDS in MPS II mice.
PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection Proportion.
Treatment with p38γ/p38δ inhibitor shows antifungal effects in vivo
AAV8‐hAAT‐FGF21 treatment improves liver fibrosis
Fig. 6. C3 deficiency resulted in partial sparing of neuron loss in hippocampal CA3 in 16-month-old APP/PS1 mice. C3 deficiency resulted in partial sparing.
TNFR1 deficiency protects against morphological alterations in the choroid plexus of APP/PS1tg/wt mice determined by TEM TNFR1 deficiency protects against.
App‐CTFs accumulate in the neurites and synaptic compartments in Aph1abc cKO Cre+ brains App‐CTFs accumulate in the neurites and synaptic compartments.
Increased astrocyte proliferation is paralleled with reduced infiltration of immune cells in mice with inducible SMOM2 expression in astrocytes at 5 dpi.
Impaired fear extinction precedes memory decline in Fmn2 mutant mice
Clinical testing of calcineurin inhibitors cyclosporine A and tacrolimus in autoimmune disorders Clinical testing of calcineurin inhibitors cyclosporine.
Stat3 promotes lung fibrosis and collagen synthesis independent of Smad3.A.Masson's trichrome stained sections of lung from gp130wt (wt), Smad3−/− (Smad3−/−),
TFE3 prevents diet‐induced obesity and metabolic syndrome
JNK signaling mediates mammary tumor growth and metastasis to lungs
SPP1 and TNC promote chemoresistance
T22‐GFP‐H6‐FdU‐induced depletion of CXCR4‐overexpressing cancer cells in tumor tissue leading to reduced spheroid formation capacity T22‐GFP‐H6‐FdU‐induced.
Inhibition of JNK signaling in breast cancer cells and lung colonization in a xenograft mouse model Inhibition of JNK signaling in breast cancer cells.
Expression of PD‐1 on PBMC and malignant exudate T cells
T22‐GFP‐H6‐FdU prevents metastasis in the M5 patient‐derived model in a CXCR4‐dependent manner T22‐GFP‐H6‐FdU prevents metastasis in the M5 patient‐derived.
Validation of astrocyte and microglial proteomic markers that increase across the ALS‐FTD spectrum Validation of astrocyte and microglial proteomic markers.
Combination of OTX‐015 and PD does not induce overt toxicity
PERK activator treatment protects neurite network
Neuro‐inflammatory cytokines, brain microglial activation, and working memory deficits are normalized using LV.IDS.ApoEII, but not LV.IDS in MPS II mice.
DOK7 gene therapy enhances life span and motor activity in ALS mice
Fig. 4. Plaque-associated microglia and astrocytes and brain cytokines were altered in APP/PS1;C3 KO mice compared to APP/PS1 mice. Plaque-associated microglia.
Inhibition of JNK signaling sensitizes mammary tumors and metastases to chemotherapy Inhibition of JNK signaling sensitizes mammary tumors and metastases.
Age‐related amyloid deposition in APPPS1‐21 mice.
Molecular and morphological analysis of Pitrm1+/− mouse brain
Nec‐1 inhibits the phosphorylation and aggregation of tau
High frequency and unique tumor‐initiating cells (TICs) in Pten/p53‐deficient mice Flow cytometry profiles of indicated tumors with the CD24 and CD49f.
Hdac3 deletion decreases AKT phosphorylation and tumor growth in Pten knockout prostate cancer Hdac3 deletion decreases AKT phosphorylation and tumor growth.
Electron microscopy of the lumbar section of the spinal cord in EAE mice after vehicle or etifoxine treatment.A.Low magnification electron micrograph showed.
SPP1 and TNC are induced by chemotherapy via JNK signaling
TGF‐β1 treatment induces the chromatin binding of Smad2/3/4 in 4T1 cells TGF‐β1 treatment induces the chromatin binding of Smad2/3/4 in 4T1 cells A, BWestern.
IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice ARepresentative.
Assessment of intracerebral micro‐hemorrhages in APP23‐transgenic mice, dosed orally with CNP520 at 30 mg/kg for 3 months Assessment of intracerebral micro‐hemorrhages.
LV.IDS and LV.IDS.ApoEII improve brain‐specific IDS activity and express supra‐physiological levels of active IDS in peripheral organs LV.IDS and LV.IDS.ApoEII.
mGPDH is not essential to muscle development
Activation of miR‐21‐3p by PPARβ/δ requires activation of the TGFβ receptor Activation of miR‐21‐3p by PPARβ/δ requires activation of the TGFβ receptor.
Validation of astrocyte and microglial proteomic markers that increase across the ALS‐FTD spectrum Validation of astrocyte and microglial proteomic markers.
Effect of memantine on Klk7‐dependent Aβ degradation activity
Therapeutic role of TR in HFD‐established diabetic mice
P2X4R blockade increases autoimmune inflammation
Growth of TKI‐resistant EGFR delE746‐A750 PC‐9 NSCLC cells is associated with elevated cellular free fatty acid and expression of FASN, and is suppressed.
Treatment with AZD5363 reduces the proportion of proliferating vascular endothelial cells and following RT, the influx of CD11b+ bone marrow‐derived cells.
Histological and mRNA analysis of the inflammatory cytokines in the vehicle‐ or etifoxine‐treated mice at onset of clinical symptoms.A–D.At day 10 p.i.,
The MEK inhibitor CI‐1040 reverses thickening, fibrosis, and angiogenesis in the parietal peritoneum of Cav1−/− mice upon exposure to PD fluidWT or Cav1−/−
Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts.
GM1 decreases neuropathology and weight loss in R6/2 mice
POLG defects cause degeneration of enhancer‐active regions of CNS
P2X4R blockade increases pro‐inflammatory gene expression after EAE
FGFR1 and TGFβ signaling activity in smooth muscle cells in a mouse atherosclerosis model FGFR1 and TGFβ signaling activity in smooth muscle cells in a.
GDF11 induces myotube atrophy in vitro
CNP520 treatment of male C57/BL6 mice for 8 weeks did not cause hair depigmentation CNP520 treatment of male C57/BL6 mice for 8 weeks did not cause hair.
Tangle formation and downregulation of miR‐132‐3p in LOAD A‐G
Bazedoxifene suppresses IL11‐mediated STAT3 signaling activity in human cancer cell lines and patient‐derived colon cancer primary cultures and organoids.
SEMA3C regulates prostate cancer cell growth
The GBS hemolytic pigment/lipid toxin induces caspase 1 activation and pyroptosis THP‐1 macrophages were treated with GBS pigment, and caspase 1 activation.
Fig. 4. Plaque-associated microglia and astrocytes and brain cytokines were altered in APP/PS1;C3 KO mice compared to APP/PS1 mice. Plaque-associated microglia.
Gene expression in the PFC of mice with an inducible neuron-specific bdnf knock-out in embryogenesis. Gene expression in the PFC of mice with an inducible.
Presentation transcript:

Target engagement of the systemic Stat3 inhibitor in APP/PS1 mice Target engagement of the systemic Stat3 inhibitor in APP/PS1 mice A–DSH‐4‐54 significantly decreased plaque growth, as assessed by IC16 immunohistochemistry, while plaque load remained unchanged. There was also no significant change in dystrophic neurite area during the treatment time (Mann–Whitney test for all comparisons; scale bars, 500 μm).E–GThe fraction of pStat3‐positive astrocytes in the peri‐plaque region was strongly reduced by the treatment with the Stat3 inhibitor (arrowheads indicate pStat3 signals; scale bars, 100 μm; Mann–Whitney test).H–KWhile no changes were seen in morphological parameters of peri‐plaque astrocytes, there was a significant increase in the process length of near‐plaque microglia, indicating higher microglial complexity (Mann–Whitney test for all comparisons).Data information: Data are represented as mean ± SEM. APP/PS1 mice treated with SH‐4‐54, n = 12 (six females and six males) mice; APP/PS1 mice treated with vehicle, n = 12 (7 females and 5 males) mice; age, 8 months. Nicole Reichenbach et al. EMBO Mol Med. 2019;emmm.201809665 © as stated in the article, figure or figure legend